Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn2+ chelator TPEN inducing oxidative stress in prostate cancer cells
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn2+ chelator TPEN inducing oxidative stress in prostate cancer cells
Authors
Keywords
-
Journal
Nanomedicine
Volume 11, Issue 10, Pages 1207-1222
Publisher
Future Medicine Ltd
Online
2016-04-15
DOI
10.2217/nnm-2015-0017
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Copper chelation selectively kills colon cancer cells through redox cycling and generation of reactive oxygen species
- (2014) Maamoun Fatfat et al. BMC CANCER
- The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn2+-chelation and inhibiting the serine protease Omi/HtrA2
- (2014) William H. Gmeiner et al. PROSTATE
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Dimeric DNA Aptamer Complexes for High-capacity–targeted Drug Delivery Using pH-sensitive Covalent Linkages
- (2013) Olcay Boyacioglu et al. Molecular Therapy-Nucleic Acids
- TPEN Induces Apoptosis Independently of Zinc Chelator Activity in a Model of Acute Lymphoblastic Leukemia andEx VivoAcute Leukemia Cells through Oxidative Stress and Mitochondria Caspase-3- and AIF-Dependent Pathways
- (2012) Miguel Mendivil-Perez et al. Oxidative Medicine and Cellular Longevity
- Zinc pyrithione induces ERK- and PKC-dependent necrosis distinct from TPEN-induced apoptosis in prostate cancer cells
- (2011) Robert E. Carraway et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Characterising the castration-resistant prostate cancer population: a systematic review
- (2011) M. Kirby et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancer
- (2011) Jianqing Lin et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Liposomal Cu-64 Labeling Method Using Bifunctional Chelators: Poly(ethylene glycol) Spacer and Chelator Effects
- (2010) Jai Woong Seo et al. BIOCONJUGATE CHEMISTRY
- Reversible Cell-Specific Drug Delivery with Aptamer-Functionalized Liposomes
- (2009) Zehui Cao et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Oxidative stress in prostate cancer
- (2009) Lakshmipathi Khandrika et al. CANCER LETTERS
- A liposome-based nanostructure for aptamer directed delivery
- (2009) Huaizhi Kang et al. CHEMICAL COMMUNICATIONS
- N,N,N′,N′-tetrakis(2-pyridylmethyl)ethylenediamine induces apoptosis through the activation of caspases-3 and -8 in human platelets. A role for endoplasmic reticulum stress
- (2009) J. J. LÓPEZ et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis
- (2008) P Makhov et al. CELL DEATH AND DIFFERENTIATION
- Pure MnTBAP selectively scavenges peroxynitrite over superoxide: Comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenan-induced pleurisy
- (2008) Ines Batinić-Haberle et al. FREE RADICAL BIOLOGY AND MEDICINE
- Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-κB-dependent pathway
- (2008) Konstantin Golovine et al. PROSTATE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started